rcca-header
Clinical Trials

A Randomized Phase 2 Single Blind Study of Temozolomide plus Radiation Therapy combined with Nivolumab or Placebo in Newly Diagnosed Adult Subjects with MGMT-Methylated (tumor O6 methylguanine DNA methyltransferase) Glioblastoma

Type of Cancer
Neuro-Oncology
Phase
Division (Location)
Hackensack, NJ
Study ID
NCT#
Brief Description
A Randomized Phase 2 Single Blind Study of Temozolomide plus Radiation Therapy combined with Nivolumab or Placebo in Newly Diagnosed Adult Subjects with MGMT-Methylated (tumor O6 methylguanine DNA methyltransferase) Glioblastoma

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.